title: Novel challenges associated with novel agents: the evolving scenario in renal cell carcinoma.
authors.affiliation: Oncologia Medica, Dipartimento di Medicina Clinica e Chirurgia, Università Federico II di Napoli, Naples, Italy.
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Di Lorenzo
authors.affiliation: Oncologia Medica, Dipartimento di Medicina Clinica e Chirurgia, Università Federico II di Napoli, Naples, Italy.
authors.forename: Carlo
authors.initials: C
authors.lastname: Buonerba
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000378:metabolism; D002292:Carcinoma, Renal Cell / Q000188:drug therapy* / Q000378:metabolism / Q000556:secondary; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor
keywords: cabozantinib; immunotherapy; kidney cancer; nivolumab; targeted therapy